A new study suggests that artificial intelligence, also known as AI, may offer a better solution. Scientists have developed a ...
A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...
New research warns that popular deep learning systems trained for cancer pathology may be relying on hidden shortcuts rather than genuine biological signals. Artificial intelligence tools are ...
Artificial intelligence is transforming medicine, but what does that mean for breast cancer screening? Researchers at UMass Chan Medical School are exploring how an AI-based tool might help identify ...
Researchers at Fred Hutch Cancer Center are testing whether a collaborative AI research platform can accelerate the pace of ...
Academia Sinica and National Taiwan University (NTU) Hospital have jointly developed PanMETAI, an AI metabolomics platform to detect the early stages of pancreatic cancer. The tabular AI model detects ...
Optellum, a 2016 spinout from the University of Oxford, has been tapped by the U.K.’s National Health Service (NHS) to use its artificial-intelligence-powered lung cancer diagnostic as part of an ...
An image-only artificial intelligence (AI) model for predicting the five-year risk of breast cancer provided stronger and more precise risk stratification than breast density assessment, according to ...